Faculty Profiles - MARUYAMA, Shoichi

Papers - MARUYAMA, Shoichi

Division display 61 - 80 of about 410 ／ All the affair displays >>

Rationale and design of the Japanese Biomarkers in Nephrotic Syndrome (J-MARINE) study Reviewed

Kurasawa, S; Kato, S; Ozeki, T; Akiyama, S; Ishimoto, T; Mizuno, M; Tsuboi, N; Kato, N; Kosugi, T; Maruyama, S

Clin Exp Nephrol Vol. 28 ( 5 ) page： 431 - 439 2024.5

Macrophage-1 antigen exacerbates histone-induced acute lung injury and promotes neutrophil extracellular trap formation Reviewed Open Access

Mizuno, T; Nagano, F; Takahashi, K; Yamada, S; Fruhashi, K; Maruyama, S; Tsuboi, N

FEBS Open Bio Vol. 14 ( 4 ) page： 574 - 583 2024.4

Proliferative glomerulonephritis with monoclonal immunoglobulin deposits and atypical pathological findings treated with corticosteroid and rituximab Reviewed Open Access

Mori, M; Tanaka, A; Maeda, K; Saito, S; Furuhashi, K; Maruyama, S

CEN Case Rep Vol. 13 ( 2 ) page： 128 - 134 2024.4

Case report: A family of atypical hemolytic uremic syndrome involving a CFH::CFHR1 fusion gene and CFHR3-1-4-2 gene duplication Reviewed Open Access

Tasaki, Y; Tsujimoto, H; Yokoyama, T; Sugimoto, N; Kitajima, S; Fujii, H; Hidaka, Y; Kato, N; Maruyama, S; Inoue, N; Wada, T

Front Immunol Vol. 15 page： 1360855 2024.3

Association between stopping renin-angiotensin system inhibitors immediately before hemodialysis initiation and subsequent cardiovascular events Reviewed Open Access

Nakamura, Y; Inaguma, D; Imaizumi, T; Kurasawa, S; Hishida, M; Okazaki, M; Fujishima, Y; Nishibori, N; Suzuki, K; Takeda, Y; Maruyama, S

Hypertens Res Vol. 47 ( 5 ) page： 1372 - 1379 2024.3

Population characteristics and diagnosis rate of chronic kidney disease by eGFR and proteinuria in Japanese clinical practice: an observational database study Reviewed Open Access

Tanaka, T; Maruyama, S; Chishima, N; Akiyama, H; Shimamoto, K; Inokuchi, S; Yokota, K; Ozaki, A

Sci Rep Vol. 14 ( 1 ) page： 5172 2024.3

特集出血傾向あるいは血栓傾向をきたす血小板減少症と血小板機能異常症【血栓傾向をきたす血小板減少症】非典型溶血性尿毒症症候群(aHUS)

加藤規利, 立枩良崇, 丸山彰一

医学のあゆみ Vol. 288 ( 8 ) page： 656 - 660 2024.2

Impact of an angulated aorto-septal relationship on cardio-cerebrovascular outcomes in patients undergoing hemodialysis. Reviewed Open Access

Nakayama T, Yamamoto J, Ozeki T, Tokoroyama S, Mori Y, Hori M, Tsujita M, Shirasawa Y, Takeda A, Kondo C, Murata M, Suzuki S, Kinoshita Y, Fukuda M, Ueki T, Ikehara N, Sugiura M, Goto T, Hashimoto H, Yajima K, Maruyama S, Koyama H, Morozumi K, Seo Y

PloS one Vol. 19 ( 2 ) page： e0298637 2024.2

Mortality and hyperkalaemia-associated hospitalisation in patients with chronic kidney disease: comparison of sodium zirconium cyclosilicate and sodium/calcium polystyrene sulfonate Reviewed Open Access

Onogi, C; Watanabe, Y; Tanaka, A; Furuhashi, K; Maruyama, S

Clin Kidney J Vol. 17 ( 2 ) page： sfae021 2024.2

Clinical characteristics of anti-GBM disease with thrombotic microangiopathy: a case report and literature review Reviewed Open Access

Nakamura, Y; Kato, N; Tatematsu, Y; Arai, Y; Mori, N; Shibata, K; Yamazaki, M; Yasui, H; Fujiwara, S; Yamakawa, T; Maruyama, S

CEN Case Rep Vol. 13 ( 1 ) page： 37 - 44 2024.2

Establishment of an adverse effect prevention protocol on plasma exchange using fresh frozen plasma prior to ABO-incompatible living donor kidney transplantation at our hospital Reviewed

Tanaka, A; Watanabe, Y; Furuhashi, K; Saito, S; Yasuda, Y; Kosugi, T; Sano, Y; Kato, M; Maruyama, S

Ther Apher Dial Vol. 28 ( 1 ) page： 152 - 157 2024.2

Clinicopathological prognostic stratification for proteinuria and kidney survival in IgA nephropathy: a Japanese prospective cohort study Reviewed Open Access

Koike, K; Kawamura, T; Hirano, K; Nishikawa, M; Shimizu, A; Joh, K; Katafuchi, R; Hashiguchi, A; Yano, Y; Matsuzaki, K; Matsushima, M; Tsuboi, N; Maruyama, S; Narita, I; Yokoo, T; Suzuki, Y

Clin Kidney J Vol. 17 ( 1 ) page： sfad294 2024.1

Overlapping Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy with Mutation in CFI in a Japanese Patient: A Case Report Open Access

Osawa Kosuke, Yamamoto Shuto, Yamano Yukiko, Kita Ayako, Okamoto Kota, Kato Noritoshi, Tatematsu Yoshitaka, Kojima Fumiyoshi, Ohya Masaki, Hara Shigeo, Murata Shin-ichi, Inoue Norimitsu, Maruyama Shoichi, Araki Shin-ichi

Internal Medicine Vol. 63 ( 12 ) page： 1777 - 1782 2024

Language：English Publisher：The Japanese Society of Internal Medicine

A 34-year-old Japanese man presented with blurred vision, headache, nausea, anemia, thrombocytopenia, and severe renal dysfunction. Thrombotic microangiopathy was initially suspected to have been caused by malignant hypertension. Antihypertensive medications did not improve his thrombocytopenia or renal dysfunction, and other diseases causing thrombotic microangiopathy were ruled out. Therefore, the patient was diagnosed with atypical hemolytic uremic syndrome. A renal biopsy revealed an overlap of thrombotic microangiopathy and C3 glomerulopathy. Genetic testing revealed c.848A>G (p.Asp283Gly), a missense heterozygous variant in the gene encoding complement factor I. Overlapping atypical hemolytic uremic syndrome and C3 glomerulopathy with complement factor I mutation is very rare, especially in Japan.

DOI： 10.2169/internalmedicine.2713-23

当院における移植後悪性腫瘍の検討 Open Access

佐野優太, 石田昇平, 佐野友康, 井上聡, 木村友和, 松川宜久, 尾関貴哉, 田中彰仁, 丸山彰一, 赤松秀輔

移植 Vol. 59 ( Supplement ) page： s326_2 - s326_2 2024

Language：Japanese Publisher：一般社団法人日本移植学会

本邦の2010年～2020年における腎移植レシピエントの死亡原因として悪性腫瘍は第1位(16.6%)であり、免疫抑制下におかれる腎移植患者は悪性腫瘍発生の高リスクとされ、悪性腫瘍の発生状況や対策は重要な課題である。2002年より2022年12月までに当院で施行した腎移植179例を対象としレトロスペクティブに検討した。悪性腫瘍は15例（8.4%）に１７種の癌が発生した。内訳は腎癌5例、大腸癌3例、膵癌2例、子宮体癌１例、前立腺癌1例、膀胱癌1例、胃癌1例、肝細胞癌1例、慢性骨髄性白血病1例、甲状腺癌1例であった。癌発症群は発症なし群と比較して、レシピエント年齢が高く、献腎移植、急性拒絶反応が多く、観察期間が長かった。また癌発症群では生存率が低かったが、生着率（death-censored）には差がなかった。癌発症例のうち癌死は4例（26.7%）であった。全例death with functioning graftであった。腎移植後は悪性腫瘍の発生率が上がり、また死亡率も高く注意が必要である。定期的な健診や予防が推奨される。当院における腎移植後悪性腫瘍の発生状況につき若干の文献的考察を加え報告する。

DOI： 10.11386/jst.59.supplement_s326_2

Open Access

CiNii Research

Complement terminal pathway inhibition reduces peritoneal injuries in a rat peritonitis model Reviewed Open Access

Kamegai, N; Kim, H; Suzuki, Y; Fukui, S; Kojima, H; Maruyama, S; Morgan, BP; Zelek, WM; Mizuno, M

Clin Exp Immunol Vol. 214 ( 2 ) page： 209 - 218 2023.12

Association between serum iron markers, iron supplementation and cardiovascular morbidity in pre-dialysis chronic kidney disease. Reviewed Open Access

Hasegawa T, Imaizumi T, Hamano T, Murotani K, Fujii N, Komaba H, Ando M, Maruyama S, Nangaku M, Nitta K, Hirakata H, Isaka Y, Wada T, Fukagawa M.

Nephrol Dial Transplant Vol. 38 ( 12 ) page： 2713 - 2722 2023.12

Current status of low-density lipoprotein apheresis treatment for patients with peripheral artery disease and chronic kidney disease in Japanese clinical database Reviewed

Watanabe, Y; Tanaka, A; Furuhashi, K; Maruyama, S

Ther Apher Dial Vol. 27 ( 6 ) page： 1000 - 1009 2023.12

Coexistence of low muscle mass and osteoporosis as a predictor of fragility fractures in long-term kidney transplant recipients Reviewed

Hori, M; Takahashi, H; Kondo, C; Matsuoka, Y; Tsujita, M; Nishihira, M; Uchida, K; Takeda, A; Morozumi, K; Maruyama, S

Am J Nephrol Vol. 54 ( 11-12 ) page： 489 - 497 2023.12

Basigin is released in extracellular vesicles derived from the renal tubular epithelium in response to albuminuria Reviewed Open Access

Watanabe, T; Maeda, K; Kato, N; Seko, H; Sugimura, M; Sato, Y; Ryuge, A; Kato, S; Kadomatsu, K; Maruyama, S; Kosugi, T

Nephrology (Carlton) Vol. 28 ( 11 ) page： 629 - 638 2023.11

Mesenchymal stem/stromal cells generated from induced pluripotent stem cells are highly resistant to senescence Reviewed Open Access

Aoi, T; Tanaka, A; Furuhashi, K; Ikeya, M; Shimizu, A; Arioka, Y; Kushima, I; Ozaki, N; Maruyama, S

Nagoya J Med Sci Vol. 85 ( 4 ) page： 682 - 690 2023.11

　 PREV - NEXT 　

<MARUYAMA, Shoichi>

Papers - MARUYAMA, Shoichi